All but 4/5 (80%) patients ≤2 years of age developed disease progression, compared with 15/32 (46.9%) > 2 years of age, however, this just failed to reach statistical significance (p=0.053).
← all excerpts
Long-term outcomes of symptomatic optic pathway glioma: 32-year experience at a single Western Australian tertiary pediatric oncology center.
1
0.0530
0.0530